Daniela Fuller
Overview
Explore the profile of Daniela Fuller including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
179
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sakamoto A, Torii S, Jinnouchi H, Fuller D, Cornelissen A, Sato Y, et al.
J Vasc Interv Radiol
. 2021 Mar;
32(6):792-801.e5.
PMID: 33677117
Purpose: To compare the long-term vascular healing responses of healthy swine iliofemoral arteries treated with a polymer-free paclitaxel-eluting stent (Z-PES, Zilver PTX) or a fluoropolymer-based paclitaxel-eluting stent (FP-PES, Eluvia). Materials...
2.
Sakamoto A, Sato Y, Kawakami R, Cornelissen A, Mori M, Kawai K, et al.
Expert Rev Cardiovasc Ther
. 2021 Jan;
19(9):801-816.
PMID: 33470872
: In-stent restenosis (ISR) has been one of the biggest limitations to the success of percutaneous coronary intervention for the treatment of coronary artery disease (CAD). The introduction of drug-eluting...
3.
Aherrahrou R, Guo L, Nagraj V, Aguhob A, Hinkle J, Chen L, et al.
Circ Res
. 2020 Oct;
127(12):1552-1565.
PMID: 33040646
Rationale: Coronary artery disease (CAD) is a major cause of morbidity and mortality worldwide. Recent genome-wide association studies revealed 163 loci associated with CAD. However, the precise molecular mechanisms by...
4.
Grainger A, Krishnaraj A, Quinones M, Tustison N, Epstein S, Fuller D, et al.
Acad Radiol
. 2020 Aug;
28(11):1481-1487.
PMID: 32771313
Rationale And Objectives: Develop a deep learning-based algorithm using the U-Net architecture to measure abdominal fat on computed tomography (CT) images. Materials And Methods: Sequential CT images spanning the abdominal...
5.
Senatus L, Lopez-Diez R, Egana-Gorrono L, Liu J, Hu J, Daffu G, et al.
JCI Insight
. 2020 Jul;
5(13).
PMID: 32641587
Despite advances in lipid-lowering therapies, people with diabetes continue to experience more limited cardiovascular benefits. In diabetes, hyperglycemia sustains inflammation and preempts vascular repair. We tested the hypothesis that the...
6.
Jinnouchi H, Guo L, Sakamoto A, Sato Y, Cornelissen A, Kawakami R, et al.
Future Med Chem
. 2020 May;
12(12):1181-1195.
PMID: 32431177
Mammalian target of rapamycin (mTOR) inhibitors have been applied to vascular coronary devices to avoid neointimal growth and have become the predominant pharmacological agents used to prevent restenosis. mTOR inhibitors...
7.
Cornelissen A, Guo L, Sakamoto A, Jinnouchi H, Sato Y, Kuntz S, et al.
Expert Rev Med Devices
. 2020 Feb;
17(3):189-200.
PMID: 32101062
: Coronary bifurcation lesions are involved in up to 20% of all percutaneous coronary interventions (PCI). However, bifurcation lesion intervention is associated with a high complication rate, and optimal treatment...
8.
Jinnouchi H, Guo L, Sakamoto A, Torii S, Sato Y, Cornelissen A, et al.
Cell Mol Life Sci
. 2019 Nov;
77(10):1919-1932.
PMID: 31720740
The presence of macrophages within the plaque is a defining hallmark of atherosclerosis. Macrophages are exposed to various microenvironments such as oxidized lipids and cytokines which effect their phenotypic differentiation...